Therapy of prostatic cancer and histopathologic follow‐up
Authors:
- 1 January 1982
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 3 (6) , 531-542
Abstract
The histopathologic follow‐up of local tumor regression of prostatic cancer under hormonal treatment or following high‐voltage therapy is an objective standard to determine a therapeutic success. This report involves 308 patients, who were continuously controlled by serial biopsies, 1, 138 punch biopsies, and 155 TURs from 1971 to 1981. On an average, there are 4.2 biopsies of each patient. The patients were treated with estradiol. They were divided into two groups by histologic classification: 1) adenocarcinomas with large and small acinar pattern (130 cases) and 2) carcinomas with cribriform and/or solid pattern, partly mixed with other glandular types (178 cases).We applied a score of 10 points to divide the histopathologic regression into three gradings: pronounced, moderate, and poor or no regression.In adenocarcinomas a pronounced regression can be seen in 67.8% following three or more years of hormonal treatment, and in 64.7% following primary high‐voltage therapy, mostly combined with hormonal treatment or orchiectomy. In adenocarcinomas with poor or no regression a percentage of 20.4 or 14.7, respectively, can be seen. In cribriform and solid carcinomas a significant difference is present between hormonal treatment and radiotherapy. Following hormonal treatment only 20.2%, but following radiotherapy 63.6% show a pronounced regression. Accordingly, 48.8% of these carcinomas show no or only poor regression under hormonal treatment after three or more years of follow‐up. Following radiotherapy, there are only 21.3%. The conformity of locally palpable finding and histopathologic grading of regression reaches 70%. If no agreement can be achieved, cases with better palpable finding than histopathologically recognizable regression prevail.Keywords
This publication has 11 references indexed in Scilit:
- Statistische Auswertung zytomorphologischer Parameter unter der gegengeschlechtlichen Therapie des Prostata-Carcinoms1981
- Prostatakarzinom: Zytologie1981
- Followup of Irradiated Prostatic Carcinoma by Aspiration BiopsyJournal of Urology, 1977
- Morphologische und klinische Behandlungsergebnisse nach kombinierter Hormon- und Strahlentherapie des Prostatakarzinoms*DMW - Deutsche Medizinische Wochenschrift, 1976
- Cyto- and histomorphogenesis of the prostate carcinomaVirchows Archiv, 1976
- Clinical Experience with Supervoltage Radiotherapy in Carcinoma of the Prostate: A Preliminary ReportJournal of Urology, 1975
- Irradiation Treatment of Carcinoma of the Prostate: A Preliminary Report Based on 8 Years of ExperienceJournal of Urology, 1972
- Cytologic Malignancy Grading of Prostatic Carcinoma by Transrectal Aspiration Biopsy:A Five-year Follow-up Study of 469 Hormone-treated PatientsScandinavian Journal of Urology and Nephrology, 1971
- Estrogen-treated prostatic cancer.The variation in responsiveness of tumor cellsCancer, 1960
- The Effect of Diethylstilbestrol and Diethylstilbestrol Dipropionate on Carcinoma of the Prostate Gland. II. Cytologic Changes Following TreatmentJournal of Urology, 1942